SALT LAKE CITY--(BUSINESS WIRE)--Foldax®, Inc. today announced the presentation of results from the first animal study of its transcatheter valve from the TRIA™ biopolymer heart valve portfolio this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback